Onconetix, Inc.
ONCO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782107
No open-market purchases or sales by Onconetix, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.9K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Onconetix, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −5 vs. Q4 2023
- Shares held
- 2.39M
- −32.7K (−1.3%) vs. Q4 2023
- Total value
- $367.8K
- −$110.9K (−23.2%) vs. Q4 2023
- New holders
- 1
- 5 more added
- Sold out
- 6
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $73.9K |
| Q1 2026 | 5 | $24.9K |
| Q4 2025 | 7 | $95.3K |
| Q3 2025 | 8 | $303.7K |
| Q2 2025 | 7 | $43.0K |
| Q1 2025 | 13 | $26.7K |
| Q4 2024 | 11 | $241.7K |
| Q3 2024 | 8 | $3.23M |
| Q2 2024 | 20 | $491.6K |
| Q1 2024 | 17 | $367.8K |
| Q4 2023 | 22 | $478.6K |
| Q3 2023 | 19 | $1.82M |
| Q2 2023 | 20 | $2.70M |
| Q1 2023 | 13 | $1.73M |
| Q4 2022 | 18 | $2.13M |
| Q3 2022 | 19 | $4.03M |
| Q2 2022 | 10 | $2.37M |
| Q1 2022 | 13 | $25.9M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Onconetix, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Financial Group Inc | 1,440,927 | $222.0K | 0.08% | 00.0% | Unchanged |
| Cetera Investment Advisers | 320,000 | $49.3K | 0.00% | +320,000 | New |
| Bank of America Corp | 125,000 | $19.3K | 0.00% | −160−0.1% | Reduced |
| Two Sigma Securities, LLC | 113,434 | $17.5K | 0.00% | +100,501+777.1% | Added |
| Fifth Third Bancorp | 96,196 | $14.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 73,513 | $11.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 53,561 | $8.25K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 53,114 | $8.18K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 38,293 | $5.90K | 0.00% | 00.0% | Unchanged |
| Bahl & Gaynor Inc | 34,710 | $5.34K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 27,721 | $4.00K | 0.00% | +10,527+61.2% | Added |
| Tower Research Capital LLC (TRC) | 8,360 | $1.29K | 0.00% | +53+0.6% | Added |
| UBS Group AG | 3,599 | $554 | 0.00% | +1,904+112.3% | Added |
| Aspire Private Capital, LLC | 600 | $92 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 128 | $20 | 0.00% | +34+36.2% | Added |
| Bogart Wealth, LLC | 13 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −322,800−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −56,400−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −50,272−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −25,926−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| O'Dell Group, LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |